Azerbaijan vs Bangladesh: Protecting minority investors: Ease of shareholder suits index (0-10)
Azerbaijan
80
in 2013
Bangladesh
80
in 2013
Azerbaijan rank
12th
Bangladesh rank
12th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Azerbaijan
- Bangladesh
How they compare
Azerbaijan currently reports 80 against 80 in Bangladesh, a difference of 0.
Across all 9 years both countries report, Bangladesh has been ahead every year.
Azerbaijan ranks 12th and Bangladesh ranks 12th of 191 countries.
Head to head by decade
| Decade | Azerbaijan | Bangladesh | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80 | 80 | 0 | — |
| 2010s | 80 | 80 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Azerbaijan or Bangladesh?
- Azerbaijan, at 80 against 80 in Bangladesh as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Azerbaijan and Bangladesh?
- 0, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Bangladesh?
- 9 years are reported by both, from 2005 to 2013.
- How do Azerbaijan and Bangladesh rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Azerbaijan ranks 12th and Bangladesh ranks 12th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.